Skip to main content
. 2018 May 15;243(8):715–724. doi: 10.1177/1535370218769420

Figure 7.

Figure 7.

Immunochemical stains show RANKL expression in control, IBDs, and DHA-treated rats. The RANKL-positive length in IBD rats was significantly longer than control rats. DHA treatment inhibited the RANKL expression induced by IBD. DHA: dihydroartemisinin; IBD: inflammatory bowel disease; RANKL: receptor activator of nuclear factor (NF)-kB ligand. (A color version of this figure is available in the online journal.)